Perceptive Advisors’s BlossomHill Therapeutics BLSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.8M Buy
+1,812,193
New +$36M 0.59% 34

Other funds holding BLSM

Perceptive Advisors's BLSM Position: Q3 2026 in Review

Perceptive Advisors opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 1,812,193 shares worth $33.8M. The stake represents 0.59% of the portfolio and ranks #34 among its holdings.

39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.

  • Perceptive Advisors held 1,812,193 shares of BlossomHill Therapeutics worth $33.8M as of Q3 2026.
  • BlossomHill Therapeutics was a new Perceptive Advisors position in Q3 2026.
  • BlossomHill Therapeutics made up 0.59% of Perceptive Advisors's portfolio in Q3 2026, its #34 holding.
  • 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.

Based on Perceptive Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.